The role of the pediatrician in preventing congenital malformations

Robert L Brent1

  • 1Alfred I. duPont Hospital for Children, Jefferson Medical College, Wilmington, DE, USA.

Pediatrics in Review
|October 4, 2011
PubMed

Insights

Advances in reproductive biology enable prevention of developmental abnormalities. While genetic factors play a role, unknown causes are more common. Genetic counseling and preconceptual planning are key for preventing environmental and genetic effects.

Area of Science:

  • Reproductive and Developmental Biology
  • Clinical Genetics
  • Clinical Teratology

Background:

  • Revolutionary advances in diagnostic techniques and epidemiology have transformed reproductive and developmental biology.
  • Physicians and scientists can now determine causes of developmental abnormalities, leading to prevention strategies.
  • Evaluation relies on a 50-year knowledge base in teratology and genetics.

Purpose of the Study:

  • To highlight the impact of scientific advancements on understanding and preventing reproductive and developmental issues.
  • To emphasize the importance of genetic counseling and preconceptual planning in mitigating risks.
  • To underscore the need for thorough evaluation of potential environmental and genetic teratogens.

Main Methods:

  • Review of advancements in reproductive and developmental biology, clinical genetics, and teratology.
  • Analysis of known and unknown causes of developmental abnormalities.
  • Discussion of preventative measures including genetic counseling, preconceptual planning, and nutritional interventions.

Main Results:

  • Genetic abnormalities contribute significantly to adverse reproductive and developmental outcomes, but unknown causes are more prevalent.
  • Over 50 environmental factors (drugs, chemicals, infections, etc.) can cause congenital malformations (CMs), and are theoretically preventable.
  • Population-level interventions like folic acid and iodine supplementation can prevent numerous birth defects globally.

Conclusions:

  • Scientific progress has significantly improved the ability to prevent and manage developmental abnormalities.
  • While genetic factors are important, addressing unknown causes and environmental exposures through counseling and planning is crucial.
  • Thorough, evidence-based evaluation using teratology principles is essential for all patients, especially those with potential exposures during pregnancy.

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...